Yield of systematic transcranial Doppler in patients with transient ischemic attack.

PubWeight™: 1.85‹?› | Rank: Top 3%

🔗 View Article (PMID 20582954)

Published in Ann Neurol on July 01, 2010

Authors

Elena Meseguer1, Philippa C Lavallée, Mikael Mazighi, Julien Labreuche, Lucie Cabrejo, Jean-Marc Olivot, Halim Abboud, Tarik Slaoui, Bertrand Lapergue, Céline Guidoux, Isabelle F Klein, Pierre-Jean Touboul, Pierre Amarenco

Author Affiliations

1: INSERM-U698 and Denis Diderot University and Medical School, Paris, France.

Articles by these authors

Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med (2013) 14.78

Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31

Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol (2009) 3.88

A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56

Clinical and imaging evidence of zolpidem effect in hypoxic encephalopathy. Ann Neurol (2007) 3.02

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00

Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87

A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74

Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55

Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51

New England Medical Center Posterior Circulation registry. Ann Neurol (2004) 2.42

Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41

CARMELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med (2008) 2.40

Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol (2005) 2.36

Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 2.33

Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26

Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology (2003) 2.22

Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16

Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke (2009) 2.10

Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06

Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke (2011) 2.03

RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution (DEFUSE) Study. Stroke (2011) 2.01

Stent-assisted endovascular thrombolysis versus intravenous thrombolysis in internal carotid artery dissection with tandem internal carotid and middle cerebral artery occlusion. Stroke (2007) 1.97

Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke (2010) 1.88

Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81

Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75

Restenosis is more frequent after carotid stenting than after endarterectomy: the EVA-3S study. Stroke (2011) 1.72

Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69

Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.64

Patients with acute stroke treated with intravenous tPA 3-6 hours after stroke onset: correlations between MR angiography findings and perfusion- and diffusion-weighted imaging in the DEFUSE study. Radiology (2008) 1.64

Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63

Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke (2005) 1.52

Protective effects of angiopoietin-like 4 on cerebrovascular and functional damages in ischaemic stroke. Eur Heart J (2013) 1.47

The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent. J Cereb Blood Flow Metab (2011) 1.47

Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46

Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. Stroke (2008) 1.46

Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol (2011) 1.44

Concurrent dolichoectasia of basilar and coronary arteries. Neurology (2005) 1.44

Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis (2013) 1.43

Ferumoxtran-10-enhanced MRI of the hypercholesterolemic rabbit aorta: relationship between signal loss and macrophage infiltration. Arterioscler Thromb Vasc Biol (2005) 1.43

Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41

Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis (2009) 1.36

Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36

Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35

High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis (2007) 1.30

Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke (2010) 1.30

Carotid plaques, but not common carotid intima-media thickness, are independently associated with aortic stiffness. J Hypertens (2002) 1.25

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation (2013) 1.20

Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20

Effect of collateral blood flow on patients undergoing endovascular therapy for acute ischemic stroke. Stroke (2014) 1.20